Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pyxis Oncology
Biotech
FDA promotes Bumpus to replace Woodcock—Chutes & Ladders
FDA promotes Bumpus to replace Woodcock. Amylyx hires new CMO to guide post-approval trials. Turtle named Spyre CEO as other leadership roles filled.
Max Bayer
Dec 1, 2023 9:48am
Hoping to pave a longer runway, Pyxis cuts staff, reprioritizes
Nov 8, 2023 5:00am
Apexigen accepts Pyxis' $16M bid 300 days after going public
May 24, 2023 9:20am
Biotechs face brutal pipeline decisions as M&A continues to lag
Aug 15, 2022 11:00am
Pyxis puts 2 drugs on backburner and a 3rd on the scrapheap
Aug 15, 2022 9:15am
Pfizer, Bayer-backed Pyxis ups IPO price
Oct 8, 2021 9:15am
